Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Kidney Transplant I: Introduction

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...

Tissue Transplantation

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...

Kidney Transplant II: Surgical Procedure

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Biomarkers of standard criteria and marginal donor lungs during ex vivo lung perfusion: A comparative study.

JHLT open·2026

Same author

Objective Assessment of Surgical Skill Using Artificial Intelligence Hand Tracking in Cardiothoracic Training: A Feasibility Study.

Interdisciplinary cardiovascular and thoracic surgery·2026

Same author

Serial assessment of modified Society for Cardiovascular Angiography and Interventions SHOCK classification in post-cardiotomy patients.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2026

Same author

Symptom Burden and Patient-Reported Outcomes in Kidney Transplant Recipients: Results From the TransplantLines Biobank and Cohort Studies.

Kidney medicine·2026

Same author

A 15-Year Single-Center Experience Treating Complex Aortic Aneurysms: Transitioning From Open to Complex Endovascular Repair.

Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists·2025

Same author

Personalized external aortic root support: The Dutch experience.

The Journal of thoracic and cardiovascular surgery·2025

Same journal

Clinician-assessed NYHA and EHRA symptom classifications only moderately reflect patient-reported quality of life in heart failure and atrial fibrillation.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation·2026

Same journal

Clinical value of computed tomography in suspected prosthetic valve dysfunction.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation·2026

Same journal

Postoperative pericardial effusion on routine echocardiography: A review of incidence, progression, and management : To dissolve or to be resolved.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation·2026

Same journal

A very, very, very late complication of a myocardial infarction.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation·2026

Same journal

Taking sustainability of cardiac catheterization to the next level: the Hartplastic showcase.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation·2026

Same journal

Beyond the catheter: patient selection and pathways in complex interventional cardiology.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jul 6, 2026

A Modified Murine Heterotopic Heart Transplant Protocol Matching Contemporary Standards of Aseptic Technique, Anesthesia, and Analgesia

A Modified Murine Heterotopic Heart Transplant Protocol Matching Contemporary Standards of Aseptic Technique, Anesthesia, and Analgesia

Published on: September 28, 2022

Guidelines for heart transplantation.

N de Jonge¹, J H Kirkels, C Klöpping

¹University Medical Center Utrecht, Utrecht, the Netherlands.

Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation

|March 18, 2008

Summary

This summary is machine-generated.

Updated guidelines define heart transplantation indications for end-stage heart failure. Key contraindications include irreversible pulmonary hypertension, active infections, and malignancy, ensuring patient suitability for this advanced treatment.

Keywords:

guidelines heart failure heart transplantation

More Related Videos

An Immunological Model for Heterotopic Heart and Cardiac Muscle Cell Transplantation in Rats

An Immunological Model for Heterotopic Heart and Cardiac Muscle Cell Transplantation in Rats

Published on: May 8, 2020

A High-Fidelity Porcine Model of Orthotopic Heart Transplantation Following Donation after Circulatory Death

A High-Fidelity Porcine Model of Orthotopic Heart Transplantation Following Donation after Circulatory Death

Published on: June 6, 2025

Related Experiment Videos

Last Updated: Jul 6, 2026

A Modified Murine Heterotopic Heart Transplant Protocol Matching Contemporary Standards of Aseptic Technique, Anesthesia, and Analgesia

A Modified Murine Heterotopic Heart Transplant Protocol Matching Contemporary Standards of Aseptic Technique, Anesthesia, and Analgesia

Published on: September 28, 2022

An Immunological Model for Heterotopic Heart and Cardiac Muscle Cell Transplantation in Rats

An Immunological Model for Heterotopic Heart and Cardiac Muscle Cell Transplantation in Rats

Published on: May 8, 2020

A High-Fidelity Porcine Model of Orthotopic Heart Transplantation Following Donation after Circulatory Death

A High-Fidelity Porcine Model of Orthotopic Heart Transplantation Following Donation after Circulatory Death

Published on: June 6, 2025

Area of Science:

Cardiology
Cardiothoracic Surgery
Transplantation Medicine

Background:

Heart failure treatment and prognosis have evolved significantly.
Existing heart transplantation criteria require updates to reflect current medical advancements.
Guidelines are essential for standardizing patient selection for heart transplantation.

Purpose of the Study:

To provide updated guidelines for heart transplantation indications and contraindications.
To define criteria for end-stage heart disease eligible for transplantation.
To outline contraindications that preclude patients from receiving a heart transplant.

Main Methods:

Development of guidelines by a committee under the Netherlands Society of Cardiology and Netherlands Association for Cardiothoracic Surgery.
Review of current understanding of heart failure management and transplantation outcomes.
Establishment of clear criteria for patient selection, including indications and contraindications.

Main Results:

Heart transplantation is indicated for end-stage heart disease unresponsive to conservative measures.
Contraindications include irreversible pulmonary hypertension, active infections, malignancy, non-compliance, severe vascular disease, and organ dysfunction.
Final acceptance relies on transplant team expertise in advanced heart failure and transplantation.

Conclusions:

Updated guidelines offer a framework for heart transplantation candidacy.
Broadly defined criteria acknowledge the complexities of end-stage heart failure and evolving therapies.
Transplant team evaluation is crucial for optimal patient selection.